Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3AL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,611
Award facts
- Contract value 100% obligated
- $10,610.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,610.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg, with an ultimate completion date of January 8, 2026. This competitively awarded, non-set-aside contract was executed on January 7, 2026, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. As a major pharmaceutical distributor, AmerisourceBergen competes on a full and open basis for federal contracts and maintains significant contract vehicles supporting military treatment facilities and veterans' healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FG3AL?
SPE2DR26FG3AL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FG3AL worth?
The government has obligated $10,611 on SPE2DR26FG3AL.
Is contract SPE2DR26FG3AL an order under another contract?
Yes. SPE2DR26FG3AL is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3AL competed?
The extent of competition for SPE2DR26FG3AL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award